During multidisciplinary rounds in the medical intensive care unit, the team evaluates a p… — USMLE Step 2 CK

During multidisciplinary rounds in the medical intensive care unit, the team evaluates a patient who repeatedly fails spontaneous breathing trials. The patient, a $69$ -year-old woman with a history of severe chronic obstructive pulmonary disease (COPD) and ischemic cardiomyopathy (ejection fraction $25\%$ ), was admitted $5$ days ago for acute hypercapnic respiratory failure and cardiogenic pulmonary edema.

On admission, she was intubated and placed on mechanical ventilation. She has since received treatment with inhaled bronchodilators, systemic glucocorticoids, and continuous intravenous furosemide, resulting in a net fluid loss of $6.5$ L and complete resolution of pulmonary crackles.

Today, her sedation is paused, and she is alert and following commands. A spontaneous breathing trial is initiated with continuous positive airway pressure (CPAP) of $5$ cm $H_2O$ . However, within $10$ minutes, her respiratory rate drops to $6$ /min with shallow tidal volumes, triggering an apnea alarm, and she is placed back on full ventilatory support.

Vital signs are temperature $37.0^\circ\text{C}$ ( $98.6^\circ\text{F}$ ), blood pressure $112/68$ mm Hg, and heart rate $84$ /min. Jugular venous pressure is $7$ cm $H_2O$ .

Laboratory studies:

Test	Result
Sodium	$138$ mEq/L
Potassium	$3.1$ mEq/L
Chloride	$86$ mEq/L
Bicarbonate	$44$ mEq/L
Blood urea nitrogen	$38$ mg/dL
Creatinine	$1.3$ mg/dL

Arterial blood gas (on assist-control ventilation, rate $12$ /min, tidal volume $400$ mL, $FiO_2$ $0.30$ ):
pH: $7.54$
$PaCO_2$ : $53$ mm Hg
$PaO_2$ : $82$ mm Hg
$HCO_3^-$ : $44$ mEq/L

Which of the following is the most appropriate next step in management to facilitate weaning from mechanical ventilation?

Administer intravenous acetazolamide and potassium chlorideAnswer
B
Increase the ventilator respiratory rate to $18$ /min
C
Administer a $0.9\%$ sodium chloride fluid bolus
D
Administer intravenous methylprednisolone
E
Initiate empiric piperacillin-tazobactam therapy

Answer

The most appropriate next step is to administer intravenous acetazolamide and potassium chloride.

The correct intervention is the administration of intravenous acetazolamide and potassium chloride. This patient developed a profound hypochloremic, hypokalemic metabolic alkalosis secondary to aggressive loop diuretic therapy (contraction alkalosis) and rapid correction of chronic hypercapnia (post-hypercapnic alkalosis). Severe alkalemia (pH

> 7.45

) inhibits central medullary chemoreceptors, leading to compensatory hypoventilation. When placed on a spontaneous breathing mode (CPAP), her intrinsic drive is too suppressed to maintain adequate minute ventilation, resulting in apnea and weaning failure. To successfully wean her, the alkalemia must be reversed. While

0.9\%

sodium chloride is the standard treatment for chloride-responsive metabolic alkalosis, this patient's severe ischemic cardiomyopathy (ejection fraction

25\%

) makes large volume fluid resuscitation prohibitively dangerous. Acetazolamide, a carbonic anhydrase inhibitor, induces a bicarbonate diuresis and rapidly corrects the alkalosis without requiring volume expansion. Concurrent potassium replacement is essential because both the existing alkalosis and acetazolamide promote renal potassium wasting.

Step-by-Step Solution

Analyze the patient's arterial blood gas and basic metabolic panel.

The patient has a primary metabolic alkalosis (pH

7.54

HCO_3^-

44

mEq/L) with appropriate respiratory compensation (

PaCO_2

53

mm Hg). She also has hypokalemia and hypochloremia.

To identify the pathophysiological mechanism causing the patient's failure to wean.

Identify the etiology of the weaning failure based on the physical exam and ventilator parameters.

The patient becomes apneic during the spontaneous breathing trial (CPAP). Severe alkalemia inhibits central brainstem chemoreceptors, suppressing the intrinsic respiratory drive (compensatory hypoventilation).

To determine why the patient cannot maintain spontaneous respirations.

Select the optimal therapy to correct the metabolic alkalosis, considering the patient's comorbidities.

Acetazolamide and potassium chloride are selected. Acetazolamide forces renal bicarbonate excretion to lower the pH, which restores the respiratory drive without requiring intravenous volume expansion.

Standard therapy for contraction alkalosis is

0.9\%

sodium chloride, but this is contraindicated in a patient with an ejection fraction of

25\%

due to the high risk of iatrogenic pulmonary edema.

Key Concept

Severe metabolic alkalosis suppresses central respiratory drive, leading to compensatory alveolar hypoventilation and failure to wean from mechanical ventilation. In volume-overloaded patients or those with severe heart failure, acetazolamide is the treatment of choice to safely correct the alkalosis.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic